Form 4: Vaccinex Director Albert Friedberg Increases Stake in Company
SEC Form 4 Filing
Albert Friedberg, a director and 10% owner of Vaccinex, Inc., has increased his beneficial ownership through recent stock purchases.
Summary
- Albert Friedberg, a director and significant shareholder of Vaccinex, Inc. (VCNX), has reported changes in his beneficial ownership of the company's stock.
- On May 29, 2024, Friedberg acquired 957 shares of common stock at a price of $4.95 per share.
- On May 30, 2024, he acquired an additional 861 shares at a weighted average price ranging from $5.17 to $5.20 per share, with the average reported as $5.195.
- These purchases were made indirectly through FCMI Parent Co., where Friedberg is the majority owner, a director, and the president.
- Following these transactions, Friedberg's indirect beneficial ownership through FCMI Parent Co. increased to 562,415 shares.
- Friedberg also indirectly owns shares through Pan Atlantic Holdings Ltd. and Friedberg Global-Macro Hedge Fund Ltd.
- He disclaims beneficial ownership of these shares except to the extent of his pecuniary interest.
- Friedberg also indirectly owns warrants to purchase Vaccinex common stock through FCMI Parent Co.
- A Limited Power of Attorney was signed on April 30, 2024, granting Dan Scheiner the authority to execute Section 16 filings on Friedberg's behalf until July 31, 2024.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. Insider buying is generally a good sign, but the document is simply reporting transactions.
Positives
- A director increasing their stake in the company can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Insider buying is often viewed as a positive sign, suggesting that those with the most knowledge of the company's prospects are optimistic about its future. However, it's important to consider the overall context and not rely solely on insider transactions when making investment decisions.
Stakeholder Impact
- The increased stake by a director could positively influence shareholder confidence.
Key Dates
| Date | Description |
|---|---|
| 04/30/2024 | Limited Power of Attorney signed, granting Dan Scheiner authority to execute Section 16 filings. |
| 05/29/2024 | Albert Friedberg acquired 957 shares of Vaccinex common stock at $4.95 per share. |
| 05/30/2024 | Albert Friedberg acquired 861 shares of Vaccinex common stock at an average price of $5.195 per share. |
| 05/31/2024 | Form 4 filing date. |
| 07/31/2024 | Expiration date of the Limited Power of Attorney. |
Keywords
Vaccinex, VCNX, Albert Friedberg, insider trading, beneficial ownership, Form 4, FCMI Parent Co., stock purchase, director, shareholder
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.